Transcaval Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using a Dedicated Self-Expanding Device

Jonathan Curio; Stephan Nienaber; Elmar W Kuhn; Kaveh Eghbalzadeh; Wael Ahmad; Arash Mehdiani; Jörg Schröder; Maria Isabel Körber; Hendrik Wienemann; Stephan Baldus; Matti Adam

doi:10.1016/j.jaccas.2024.102320

Transcaval Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using a Dedicated Self-Expanding Device

JACC Case Rep. 2024 Apr 4;29(10):102320. doi: 10.1016/j.jaccas.2024.102320. eCollection 2024 May 15.

Affiliations

¹ Department of Cardiology, Heart Center Cologne, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
² Department of Heart Surgery, Heart Center Cologne, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
³ Department of Vascular and Endovascular Surgery, University Hospital of Cologne, Cologne, Germany.
⁴ Department of Cardiac Surgery, Medical Faculty and Rheinisch-Westfälische Technische Hochschule (RWTH) University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
⁵ Department of Cardiology, Medical Faculty and RWTH University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Abstract

Novel dedicated devices allow transcatheter treatment of pure aortic regurgitation (AR). The JenaValve Trilogy Heart Valve System was introduced as the first dedicated and on-label AR transcatheter aortic valve replacement system, implementing a locator-based and calcium-independent anchoring mechanism. Here, we present the first-in-human transcatheter aortic valve replacement for pure AR via a transcaval access in a patient with prohibitive alternative arterial accesses.

Keywords: TAVR; alternative access; aortic regurgitation; electrosurgery; transcaval.

Publication types

Case Reports